Dreamit Founders in Forbes 30 Under 30

We wanted to take a moment to congratulate the many Dreamit founders who found themselves on the Forbes 30 Under 30 lists in the health and science categories. Forbes chose them for being some of the "brightest young entrepreneurs, innovators and game changers" in their industries. The Forbes list is "the most definitive gathering of today’s leading young change-makers and innovators in the U.S." We can attest to that, and we're tremendously proud of the accomplishments of these founders. 

TowerView Health (Health Category)

After he was diagnosed with cancer, Nick Valilis was surprised by how difficult it was to remember to take his pills. So he teamed up with his college roommates to found TowerView Health, which sells a smart pill box with custom trays of medication, solving a problem for the over 50% of people on medication who do not take their medication as prescribed.

Redox (Health Category) 

Niko Skievaski, founder of Redox, is solving one of the biggest problems in healthcare: getting data from one place to another. Skievaski's company has raised $4 million to make an API that works as a bridge between healthcare data and the software that uses it, translating patients' records across platforms. So far the company has partnered with more than 1,000 software vendors.

DNASimple (Science Category)

Olivier Noel is the cofounder of DNAsimple, which helps accelerate genetic research by connecting DNA donors with research scientists, simplifying the process enormously. Thousands of studies are delayed or canceled due to lack of donors every year. That means treatments and cures are delayed or canceled due to lack of donors every. Scientists have a ready access to samples, and donors get a little extra cash.

Freenome (Health Category)

Freenome founder Gabe Ott went through Dreamit NYC in 2015 for his company Acorn. After Acorn, Ott cofounded Freenome,  which has raised $7 million to develop a blood test that can screen for multiple types of cancer by looking for changes in DNA fragments over time. Even with ever-improving cancer treatments, a patient's best shot at survival is still early diagnosis. Unfortunately, diagnosis still usually doesn't happen until symptoms of cancer appear. Freenome solves this problem. 

We're now accepting applications for our spring health tech program. Learn more about the program and join an incredible network of alumni, mentors, investors, and potential customers at Dreamit, the top growth focused health tech accelerator in the country. 

Charles LaCalle